Reactivity of Platelia Aspergillus galactomannan antigen with piperacillin-tazobactam:: Clinical implications based on achievable concentrations in serum

被引:55
作者
Singh, N
Obman, A
Husain, S
Aspinall, S
Mietzner, S
Stout, JE
机构
[1] VA Med Ctr, Infect Dis Sect, Pittsburgh, PA 15240 USA
[2] Univ Pittsburgh, Med Ctr, Pittsburgh, PA 15260 USA
关键词
D O I
10.1128/AAC.48.6.1989-1992.2004
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The possible reactivities of commonly used antibiotics of fungal, nonfungal, and nonmicrobial or synthetic sources with the Platelia Aspergillus galactomannan assay were assessed. For drugs that tested positive, the minimal concentration of the antibiotic in serum that yielded a positive test (index, > 0.5) was determined. At undiluted concentrations, piperacillin and multiple lots of piperacillin-tazobactam tested positive, whereas amoxicillin, ampicillin-sulbactam, nafcillin, cefazolin, ceftazidime, erythromycin, gentamicin, and levofloxacin tested negative. All three lots of piperacillin-tazobactam and all bags within each lot tested positive, with a mean index value of 5.168. At achievable concentrations in serum, however, only one of three lots of piperacillin-tazobactam yielded a positive test. Concentrations of 75, 150, and 300 mug/ml of serum tested positive with the Platelia Aspergillus enzyme immunoassay, whereas lower concentrations, mimicking the trough levels, tested negative. Thus, while achievable serum piperacillin-tazobactam concentrations may potentially result in a positive test for galactomannan, the timing of the collection of serum samples from patients may influence the test results, with reactivity being less likely in samples collected at trough levels or prior to the administration of a dose of the antibiotic.
引用
收藏
页码:1989 / 1992
页数:4
相关论文
共 17 条
  • [1] Treatment with piperacillin-tazobactam and false-positive Aspergillus galactomannan antigen test results for patients with hematological malignancies
    Adam, O
    Aupérin, A
    Wilquin, F
    Bourhis, JH
    Gachot, B
    Chachaty, E
    [J]. CLINICAL INFECTIOUS DISEASES, 2004, 38 (06) : 917 - 920
  • [2] Detection of Aspergillus galactomannan antigen in foods and antibiotics
    Ansorg, R
    van den Boom, R
    Rath, PM
    [J]. MYCOSES, 1997, 40 (9-10) : 353 - 357
  • [3] FLEMING A, 1929, BRIT J EXP PATHOL, V10, P266
  • [4] Risk factors for invasive aspergillosis in liver transplant recipients
    Fortún, J
    Martín-Dávila, P
    Moreno, S
    de Vicente, E
    Nuño, J
    Candelas, A
    Bárcena, R
    García, M
    [J]. LIVER TRANSPLANTATION, 2002, 8 (11) : 1065 - 1070
  • [5] HUSAIN S, 2004, AM J TRANSPLANT, V4, P1
  • [6] Efficacy of galactomannan antigen in the platelia Aspergillus enzyme immunoassay for diagnosis of invasive aspergillosis in liver transplant recipients
    Kwak, EJ
    Husain, S
    Obman, A
    Meinke, L
    Stout, J
    Kusne, S
    Wagener, MM
    Singh, N
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2004, 42 (01) : 435 - 438
  • [7] LATGE JP, 1994, INFECT IMMUN, V62, P5424
  • [8] Use of circulating galactomannan screening for early diagnosis of invasive aspergillosis in allogeneic stem cell transplant recipients
    Maertens, J
    Van Eldere, J
    Verhaegen, J
    Verbeken, E
    Verschakelen, J
    Boogaerts, M
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2002, 186 (09) : 1297 - 1306
  • [9] Preston SL, 1999, ANTIMICROBIAL, P850
  • [10] Prospective sandwich enzyme-linked immunosorbent assay for serum galactomannan: Early predictive value and clinical use in invasive aspergillosis
    Rohrlich, P
    Sarfati, J
    Mariani, P
    Duval, M
    Carol, A
    SaintMartin, C
    Bingen, E
    Latge, JP
    Vilmer, E
    [J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1996, 15 (03) : 232 - 237